Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsBliss gvs pharma

    Bliss Gvs Pharma

    Jump to

    • Stocks to Watch Today: Monte Carlo, Belrise, Emcure Pharma, GPT Infra, Surana Telecom, Vikran Engineering, Federal Bank in focus on 24 December

      Stocks to Watch, 24 December: Stocks like Monte Carlo Fashions, Rail Vikas Nigam, Zydus Lifesciences, Emcure Pharmaceuticals, GPT Infraprojects, SJS Enterprises, Surana Telecom, Vikran Engineering, Ajanta Pharma, Coal India, Federal Bank, Bliss GVS Pharma, GAIL India, Belrise Industries, and Marc Technocrats will be in focus on December 24.

    • Bliss GVS Consolidated September 2025 Net Sales at Rs 244.40 crore, up 12.27% Y-o-Y

    • Stocks to Watch on Muhurat Trading day: Axis Bank, Marathon Nextgen, Geojit Financial, NSDL, Unimech Aerospace in focus on 21 October

      Stocks to Watch, 21 October: Stocks like Geojit Financial Services, State Bank of India, National Securities Depository, Axis Bank, Marathon Nextgen Realty, Unimech Aerospace and Manufacturing, Bliss GVS Pharma, and South Indian Bank will be in focus on October 21.

    • BNP Paribas Financial Markets acquires 1.9% stake in RBL Bank for Rs 377 crore

      RBL Bank shares clocked 9 percent rally on Monday to close at Rs 326.65 with strong volumes after the Emirates NBD Bank received its board approval to acquire up to 60 percent equity stake in the bank by infusing up to Rs 26,850 crore.

    • Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y

    • Bliss GVS Standalone June 2025 Net Sales at Rs 163.36 crore, up 9.67% Y-o-Y

    • Bliss GVS Standalone March 2025 Net Sales at Rs 156.00 crore, down 4.77% Y-o-Y

    • Bliss GVS Consolidated March 2025 Net Sales at Rs 197.99 crore, down 0.07% Y-o-Y

    • Bliss GVS Consolidated December 2024 Net Sales at Rs 210.42 crore, up 4.83% Y-o-Y

    • Bliss GVS Consolidated September 2024 Net Sales at Rs 217.68 crore, up 2.74% Y-o-Y

    • Bliss GVS Standalone September 2024 Net Sales at Rs 182.65 crore, up 6.61% Y-o-Y

    • Bliss GVS Consolidated June 2024 Net Sales at Rs 183.64 crore, up 15.12% Y-o-Y

    • Bliss GVS Standalone June 2024 Net Sales at Rs 148.96 crore, up 36.67% Y-o-Y

    • Bliss GVS Consolidated March 2024 Net Sales at Rs 198.13 crore, up 7.22% Y-o-Y

    • Bliss GVS Standalone March 2024 Net Sales at Rs 163.82 crore, up 14.22% Y-o-Y

    • Bliss GVS Consolidated December 2023 Net Sales at Rs 200.72 crore, down 2.43% Y-o-Y

    • Bliss GVS Standalone December 2023 Net Sales at Rs 161.33 crore, down 4.42% Y-o-Y

    • Bliss GVS Consolidated September 2023 Net Sales at Rs 211.88 crore, up 22.88% Y-o-Y

    • Bliss GVS Standalone September 2023 Net Sales at Rs 171.32 crore, up 23.38% Y-o-Y

    • Bliss GVS Consolidated June 2023 Net Sales at Rs 159.52 crore, down 15.45% Y-o-Y

    • Bliss GVS Standalone March 2023 Net Sales at Rs 143.42 crore, up 3.7% Y-o-Y

    • Bliss GVS Consolidated March 2023 Net Sales at Rs 184.78 crore, up 10.6% Y-o-Y

    • Bliss GVS Pharma share price falls on observations from USFDA

      The company shall prepare detailed response to the observations, which will be submitted to the USFDA within the stipulated timelines.

    • Bliss GVS Consolidated December 2022 Net Sales at Rs 205.72 crore, down 4.87% Y-o-Y

    • Bliss GVS Standalone December 2022 Net Sales at Rs 168.79 crore, down 11.44% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347